πŸ‡ΊπŸ‡Έ FDA
Patent

US 8198242

Variants of C-type natriuretic peptide

granted A61KA61K38/00A61K38/22

Quick answer

US patent 8198242 (Variants of C-type natriuretic peptide) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61K38/22, A61K38/2242, A61K47/10